USPTO serial 88939015
SEDA-Q
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEAN, JULES J.
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SEDA-Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NEW YORK, NY, US
San Francisco, CA, US
San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas W. Galvani
Thomas W. Galvani THOMAS W. GALVANI, P.C.3519 E. SHEA BLVD, SUITE 129PHOENIX, AZ 85028UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations | ACTIVE | Dec 31, 2019 |
| 010 | Surgical apparatus and instruments for medical, dental and veterinary use for performing parenteral infusions in the field of medical and surgical procedures; Medical devices, namely, parenteral infusion pumps and dispensers for delivering measured amounts of solutions into the bloodstream over time; Medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time | ACTIVE | Dec 31, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MADRYN BIOQ SPV, LLC
- Other trademarks owned by BioQ Pharma, Inc.
- Other trademarks owned by BioQ Pharma, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SEDA-Q
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 4, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 4, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 23, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2021 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 21, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 12, 2021 | IUAF | USE AMENDMENT FILED | — |
| May 12, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 8, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 13, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 4, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 4, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 4, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 4, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 4, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2020 | NWAP | NEW APPLICATION ENTERED | — |